Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer. - Muliaditan T; Opzoomer JW; Caron J; Okesola M; Kosti P; Lall S; Van Hemelrijck M; Dazzi F; Tutt A; Grigoriadis A; Gillett CE; Madden SF; et al. (Clinical cancer research : an official journal of the American Association for Cancer Research, 2018)